Previous 10 | Next 10 |
Kasey Rosado has been named interim CFO of regenerative medicine company Athersys ( NASDAQ: ATHX ). The appointment comes as the firm announced engagement with Ankura Consulting Group. As Senior Managing Director at Ankura, Ms. Rosado provides advisory support for doze...
Brings Operational Excellence and Financial Experience to Leadership Team Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem ® (invimestrocel) for critical care indications, announces today its engagement with Ankura Consulting Group...
Gainers: REX American Resources ( REX ) +195% . SQL Technologies ( SKYX ) +64% . Athersys ( ATHX ) +66% . JAKKS Pacific ( JAKK ) +34% . Aridis Pharmaceuticals ( ARDS ) +33% . Better Therapeutics ( BTTX ) +32% . Co...
If you’re an active trader or looking for stock market news today, this is probably the one-millionth headline you’ve read with the phrase “Recession Begins” in the title. Apologies for that, but it’s true; we’re officially in a technical recession....
Athersys is running on fumes with cash burn that exceeds its resources. The withdrawal of its stock purchase agreement was a tough punch for a reeling contestant. Athersys has a valuable, partially derisked asset in MultiStem but it may be too little, too late for current sharehol...
Athersys, Inc. (Nasdaq: ATHX) today announced that its equity purchase agreement with Aspire Capital Fund LLC (Aspire Capital) has been terminated. The Company continues to evaluate alternative financing options to support continuing operations. After several discussions with Aspire Cap...
Thinking about buying stock in Cowen, OneConnect Financial Tech, Faraday Future Intelligent Electric, RA Medical Systems, or Athersys? PR Newswire NEW YORK , July 5, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for COWN, OC...
Athersys, Inc. (Nasdaq: ATHX) today announced the Company’s slate of director candidates for its 2022 Annual Meeting of Stockholders being held on Thursday, July 28, 2022, at 8:30 a.m. ET. As previously announced, in connection with the Company’s cost-cutting and restructu...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com We’re entering the final day of trading for the week with a look at the biggest pre-market stock movers for Friday! Moving stocks this morning is delisting news, insider buyi...
Clinical-stage biotech Athersys (NASDAQ:ATHX) is trading lower in the morning hours Thursday after the company postponed its annual meeting of stockholders citing a need to add a proposal to implement a reverse stock split. Accordingly, the meeting initially set for next week will now be held...
News, Short Squeeze, Breakout and More Instantly...
Athersys, Inc. (OTC: ATHX), a regenerative medicine company developing MultiStem ® (invimestrocel) cell therapy for critical care indications, announced financial results for the three and nine months ended September 30, 2023 and provided a business update. Third Quarter 2023 and...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
Athersys, Inc. (Nasdaq: ATHX), (“Athersys” or the “Company”) a cell therapy and regenerative medicine company developing MultiStem ® (invimestrocel) for critical care indications, announces it has entered into a warrant exercise inducement offer letter to ra...